Company / Return on Equity (ROE)
Xencor Inc Return on Equity (ROE) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-14.5%
FY2025
5-year range
-34.3% / 4.5%
FY2021-FY2025
Trend
+57.9%
vs FY2024
Sector context
#68 of 190
Health Care
What the data says
Xencor Inc reports negative total equity of -14.5% in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-14.5% in FY2025 with a 5-year CAGR of -2.4%.
Improved from -20.1% to -14.5% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -6.9pp
- 5-Year Change
- -2.4pp
- 10-Year Change
- -
Sector benchmark
#68 of 190 in Health CareTop 36% of 190This company -14.5% Sector average -50.3%
▼
+71.3% above sector average
Key checks
Key Insights
- In FY2025, return on equity (roe) increased 57.9% year-over-year.
- Currently 35.9pp above the Health Care sector average.
- Peak return on equity (roe) was recorded in FY2018.
- Lowest return on equity (roe) in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.27 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -14.5% | +57.9% |
| FY2024 | -34.3% | -70.6% |
| FY2023 | -20.1% | -165.1% |
| FY2022 | -7.6% | -267.5% |
| FY2021 | 4.5% | +137.4% |
| FY2020 | -12.1% | +0.4% |
| FY2019 | -12.2% | -191.1% |
| FY2018 | 13.4% | +209.8% |
| FY2017 | -12.2% | -191.1% |
| FY2016 | 13.4% | +223.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026